fda warning peptides bpc 157 october 2025 FDA's Review Of Signals A Growing Public Health Challenge The hype around a new

The hype around a new class of injectable drugs is in overdrive, but they have yet to be properly tested. Read the full story from Kishor Napier Raman at the link in bio., Photo: Oscar Colman FDA Scientists Raise Peptide Concerns Ahead of Committee Meeting MedPage Today On August 15 2025, the U.S. Food & Drug Administration (FDA) issued a Warning Letter to Platinum Biologics LLC for marketing umbilicalcordderived products including exosome products (NanoEx & Nano Xsomes) without approval. This is the first vote from the FDA's Pharmacy Compounding Advisory Committee on one of 7 peptides up for consideration. While the committee advises through these votes, ultimately the FDA will make

SKU: 93050508781 · From www.asociacionchamorro.org